Park Ha Biological Technology Co., Ltd. filed a Form F-1 registration statement for an initial public offering on 2024-08-26. It has amended it 8 times. It filed its final prospectus on 2026-01-28, at a public offering price of $0.11 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our Class A Ordinary Shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “BYAH”.From the 424B4 filed 2026-01-28
Shares offered
We are offering on a best -efforts basis 21,875,000 units (the “Units”), with each Unit consisting of (i) one class A ordinary share, par value $0.00002 per share (each, a “Class A Ordinary Share,”) and collectively, the “Class A Ordinary Share”) and (ii) one warrant to purchase one Class A Ordinary Share (up to nine Class A Ordinary Shares pursuant to the zero exercise price option as described further below) (each, a “Warrant,” and collectively, the “Warrants”).From the 424B4 filed 2026-01-28
Offering price
We are offering the Units at the public offering price of $0.112 per Unit.From the 424B4 filed 2026-01-28
Use of proceeds
We currently intend to use the net proceeds to us from this offering for the expansion in directly operated stores.From the 424B4 filed 2026-01-28
Revenue
Our total revenue increased by $386,269 to $1,239,197 for the six months ended April 30, 2025 from $852,928 for the six months ended April 30, 2024.From the F-1/A filed 2025-12-05
Net loss or income
We recorded net loss of $19,835,994 for the six months ended April 30, 2025 and net income of $48,900 for the six months ended April 30, 2024.From the F-1/A filed 2025-12-05
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-08-26 | Registration statement filed (foreign issuer) | F-1 |
| 2024-09-18 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-10-09 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-11-06 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-12-06 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-12-20 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-12-27 | Final prospectus filed: the offering is priced | 424B4 |
| 2025-09-19 | Registration statement filed (foreign issuer) | F-1 |
| 2025-09-25 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-12-05 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-01-23 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-01-28 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Park Ha Biological Technology Co., Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.